2359. Relative effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S vaccines in adults at higher risk for severe COVID-19 outcomes

BACKGROUND: Older age ( > 65 years) and underlying chronic medical conditions are risk factors associated with severe COVID-19 outcomes. In this study, we evaluated the relative vaccine effectiveness (rVE) of a primary series of mRNA-1273 (2 doses) versus BNT162b2 (2 doses) or Ad26.COV2.S (1 dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Van Hung, Boileau, Catherine, Bogdanov, Alina, Zeng, Ni, Bonafede, Mac, Ducruet, Thierry, Rosen, Andrew M, Martin, David, Esposito, Daina, Van de Velde, Nicolas, Kopel, Hagit, Mansi, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676982/
http://dx.doi.org/10.1093/ofid/ofad500.1980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676982/
http://dx.doi.org/10.1093/ofid/ofad500.1980

Ejemplares similares